United States - English - NLM (National Library of Medicine)

alternative pharmacy - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), robinia pseudoacacia bark (unii: 7tpc058owy) (robinia pseudoacacia bark - unii:7tpc058owy) - to temporarily relieve the symptoms of gas and bloating. to temporarily relieve the symptoms of gas and bloating.

United States - English - NLM (National Library of Medicine)

silver star brands - sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), robinia pseudoacacia bark (unii: 7tpc058owy) (robinia pseudoacacia bark - unii:7tpc058owy), nutmeg (unii: aee24m3mq9) (nutmeg - unii:aee24m3mq9), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), activated charcoal (unii: 2p3vwu3h10) (ac - uses*: homeopathic remedy to relieve nausea, heartburn, upset stomach, diarrhea, gas and bloating. *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. temporarily relieves nausea, heartburn, indigestion, upset stomach, diarrhea, gas & bloating.

United States - English - NLM (National Library of Medicine)

apotheca company - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), robinia pseudoacacia bark (unii: 7tpc058owy) (robinia pseudoacacia bark - unii:7tpc058owy) - uses: to help alleviate the symptoms of gas and bloating. to help alleviate the symptoms of gas and bloating. other information: safety sealed for your protection.  do not use if seal around neck is broken or missing.

United States - English - NLM (National Library of Medicine)

holistic haven - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), robinia pseudoacacia bark (unii: 7tpc058owy) (robinia pseudoacacia bark - unii:7tpc058owy) - for the temporary relief of gas, bloating, acid reflux, and stomach upset. for the temporary relief of gas, bloating, acid reflux, and stomach upset.

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - arsenic trioxide - leukemia, promyelocytic, acute - antineoplastic agents - arsenic trioxide is indicated for induction of remission, and consolidation in adult patients with:newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 103/μl) in combination with all-trans-retinoic acid (atra)relapsed/refractory acute promyelocytic leukaemia (apl)(previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the promyelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rar-alpha) gene.the response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.

European Union - English - EMA (European Medicines Agency)

mylan ireland limited - arsenic trioxide - leukemia, promyelocytic, acute - antineoplastic agents - arsenic trioxide mylan is indicated for induction of remission, and consolidation in adult patients with:- newly diagnosed low to intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 103/μl) in combination with all trans retinoic acid (atra)- relapsed/refractory acute promyelocytic leukaemia (apl) (previous treatment should have included a retinoid and chemotherapy)characterised by the presence of the t(15;17) translocation and/or the presence of the promyelocytic leukaemia/retinoic acid receptor alpha (pml/rar alpha) gene.the response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not beenexamined.

European Union - English - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - arsenic trioxide - leukemia, promyelocytic, acute - antineoplastic agents - arsenic trioxide medac is indicated for induction of remission, and consolidation in adult patients with:newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 10³/μl) in combination with all-trans-retinoic acid (atra)relapsed/refractory apl (previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rarα) gene.the response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.

Canada - English - Health Canada

teva canada limited - arsenic trioxide - solution - 10mg - arsenic trioxide 10mg - antineoplastic agents

Canada - English - Health Canada

teva canada limited - arsenic trioxide - solution - 12mg - arsenic trioxide 12mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

standard homeopathic company - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide 30 [hp_x] in 1 g - burning nasal discharge or diarrhea